Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Brimonidine Tartrate and Timolol Maleate Eye Drops

Approval Number

国药准字H20233018

Company山东齐鲁制药有限公司

Registration Date

January 9, 2023

Drug Information

Generic Name

溴莫尼定噻吗洛尔滴眼液

Dosage Form

滴眼剂

Strength

5ml: 酒石酸溴莫尼定10.0mg和马来酸噻吗洛尔25.0mg（以C₁₃H₂₄N₄O₃S计）

Drug Type

化学药品

Registration Date

January 9, 2023

Company Information

Applicant Company

Company Name山东齐鲁制药有限公司

Company Address

山东省济南市高新区新泺大街317号

Manufacturing Company

Company Name山东齐鲁制药有限公司

Company Address

山东省济南市高新区新泺大街317号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

溴莫尼定噻吗洛尔滴眼液 - NMPA 批准文号 | MedPath